Italy· 047791025
AJOVY*3 siringhe preriempite SC 1,5 ml 225 mg
A fremanezumab product containing fremanezumab, registered in Italy by TEVA GmbH, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Fremanezumab is registered in 15 of 19 countries.
Countries holding a registration under ATC N02CD03 (fremanezumab), each read from that country’s own register.
- This record: Italy
- 10 of them publish a price we can compare per daily dose
Fremanezumab · ATC N02CD03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
- Active substance
- Fremanezumab
- Manufacturer
- TEVA GmbH
- Country
- Italy (IT)
- ATC code
- N02CD03
- ATC class
- Fremanezumab
- Defined daily dose
- 7.5 mg, P
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic047791025AJOVY*3 siringhe preriempite SC 1,5 ml 225 mgEUR 2104.27
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fremanezumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAJOVYTeva GmbH, Ulm
- United StatesAJOVYTeva Pharmaceuticals USA, Inc.
- SwitzerlandAjovy
- FinlandAJOVYTeva GmbH
- United KingdomAjovy 225mg/1.5ml solution for injection pre-filled pensTeva UK Ltd
- BelgiumAjovy 225 mgTeva
- CanadaAJOVYTEVA CANADA LIMITED
- SpainAJOVY 225 MG SOLUCION INYECTABLE EN JERINGA PRECARGADATeva Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Ajovy
- Iceland · Ajovy
- Liechtenstein · Ajovy
- Norway · Ajovy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c65722d8-3e30-4144-8d6e-e0f8d1d9d664 GET /v1/drugs/c65722d8-3e30-4144-8d6e-e0f8d1d9d664?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 2104.27,
"source": "aifa",
"currency": "EUR",
"strength": "FREMANEZUMAB 225MG 1,5ML 3 UNITA' USO PARENTERALE",
"substance": "Fremanezumab",
"equivalence_group": "LDW",
"transparency_flag": null
}See everything about fremanezumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.